Related Experiment Videos
Elastin mutation and cardiac disease
1Mothercare Unit of Clinical Genetics and Fetal Medicine, Institute of Child Health, 30, Guilford Street, London WC1N 1EH, United Kingdom.
Insights
Mutations in the Elastin gene cause familial supravalvular aortic stenosis (SVAS) and Williams
Area of Science:
- Cardiovascular Genetics
- Molecular Biology
- Medical Genetics
Background:
- Structural cardiac diseases, including familial supravalvular aortic stenosis (SVAS), have complex molecular underpinnings.
- Elastin gene mutations have been implicated in the pathogenesis of SVAS and Williams' syndrome (WS).
Purpose of the Study:
- To review the evidence linking Elastin gene mutations to SVAS and WS.
- To explore the mechanisms by which these mutations lead to cardiac abnormalities.
- To discuss the clinical implications of identifying Elastin mutations.
Main Methods:
- Literature review focusing on genetic studies and clinical case reports.
- Analysis of proposed pathomechanisms for Elastin-related cardiovascular disease.
Main Results:
- Strong association demonstrated between Elastin gene mutations and the development of SVAS and WS.
- Elastin dysfunction due to mutations is a key factor in the pathogenesis of these conditions.
Conclusions:
- Identification of Elastin mutations is crucial for prenatal and presymptomatic diagnosis of SVAS and WS.
- Understanding these genetic links allows for potential earlier medical intervention and guides future research.
- Elastin mutation analysis has significant implications for clinical practice and therapeutic strategies.
Abstract:
Characterization of the molecular basis of structural cardiac disease includes elucidating the pathogenesis of certain vascular disease by demonstrating mutations of the Elastin gene as the cause of familial supravalvular aortic stenosis (SVAS) and Williams' syndrome (WS). Defining the etiology of SVAS has clinical implications in terms of prenatal and presymptomatic diagnosis and possible earlier intervention with medical therapy. This review considers the evidence relating Elastin mutations to SVAS and WS and outlines the possible mechanisms by which these mutations give rise to cardiac disease. Finally, the implications which Elastin mutation identification has on current clinical practice and future research directions are considered.